23G微创玻璃体切除术后眼内炎临床分析

摘要

目的 分析23 G微创玻璃体切除术后眼内炎的临床特点.方法 回顾分析2013年1月～2017年1月同一医师行23 G微创玻璃体手术后发生眼内炎的患者,开放性眼外伤患者除外.结果 共有1 169例患者纳入研究,发生眼内炎2例,发生率为0.17％,发生时间为首次手术后2～3d.2例患者均再次行23 G急诊玻璃体切除术联合术中抗生素灌注,手术后眼内炎得到控制,最终矫正视力分别为0.15和0.4.结论 手术前后用5％聚维酮碘冲洗结膜囊以及规范应用抗生素可能是预防微创玻璃体手术后眼内炎的重要方法,及时行玻璃体切除术联合应用抗生素可能使眼内炎患者获得较好预后.%Objective To analyze the clinical features and the possible risk factors of endophthalmitis after 23 G minimally invasive vitrectomy (MIVS).Methods Data of patients who suffered from endophthalmitis after 23 G MIVS from January 2013 to January 2017 were analyzed retrospectively and all the surgery were performed by the same doctor.The patients who had open ocular trauma were excluded.Results A total of 1 169 patients were included in the study.Endophthalmitis happened in two cases and the incidence was 0.17％.The interval between MIVS and diagnosis of endophthalmitis was 2 ～ 3 days.Both of the two patients were performed pars plana vitrectomy (PPV) emergency combined with antibiotics infusion.Endophthalmitis was controlled and the final corrected visual acuity were 0.15 and 0.4 respectively.Conclusions Flushing the conjunctival sac with 5％ povidone before and after the operation is suggested for the prophylaxis of endophthalmitis.PPV emergency combined with antibiotics may improve prognosis in some patients.